Phase 3 Readout
AURA: Phase 3 Topline: A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotal
August 15, 2028. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- August 15, 2028
- Company
- Aura Biosciences, Inc. (AURA)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotal
- Indication
- Uveal Melanoma; Ocular Melanoma; Choroidal Melanoma